Your browser doesn't support javascript.
loading
Development of BET inhibitors as potential treatments for cancer: A new carboline chemotype.
Hill, Matthew D; Quesnelle, Claude; Tokarski, John; Fang, Haiquan; Fanslau, Carolynn; Haarhoff, Zuzana; Kramer, Melissa; Madari, Shilpa; Wiebesiek, Amy; Morrison, John; Simmermacher-Mayer, Jean; Sinz, Michael; Westhouse, Richard; Xie, Chunshan; Zhao, Jiuqiao; Huang, Lisa; Sheriff, Steven; Yan, Chunhong; Marsilio, Frank; Everlof, Gerry; Zvyaga, Tatyana; Lee, Francis; Gavai, Ashvinikumar V; Degnan, Andrew P.
Afiliação
  • Hill MD; Bristol Myers Squibb Research and Development, 100 Binney St, Cambridge, MA 02142-1096, USA. Electronic address: matthew.hill@bms.com.
  • Quesnelle C; Bristol Myers Squibb Research and Development, 100 Binney St, Cambridge, MA 02142-1096, USA.
  • Tokarski J; Bristol Myers Squibb Research and Development, 100 Binney St, Cambridge, MA 02142-1096, USA.
  • Fang H; Bristol Myers Squibb Research and Development, 100 Binney St, Cambridge, MA 02142-1096, USA.
  • Fanslau C; Bristol Myers Squibb Research and Development, 100 Binney St, Cambridge, MA 02142-1096, USA.
  • Haarhoff Z; Bristol Myers Squibb Research and Development, 100 Binney St, Cambridge, MA 02142-1096, USA.
  • Kramer M; Bristol Myers Squibb Research and Development, 100 Binney St, Cambridge, MA 02142-1096, USA.
  • Madari S; Bristol Myers Squibb Research and Development, 100 Binney St, Cambridge, MA 02142-1096, USA.
  • Wiebesiek A; Bristol Myers Squibb Research and Development, 100 Binney St, Cambridge, MA 02142-1096, USA.
  • Morrison J; Bristol Myers Squibb Research and Development, 100 Binney St, Cambridge, MA 02142-1096, USA.
  • Simmermacher-Mayer J; Bristol Myers Squibb Research and Development, 100 Binney St, Cambridge, MA 02142-1096, USA.
  • Sinz M; Bristol Myers Squibb Research and Development, 100 Binney St, Cambridge, MA 02142-1096, USA.
  • Westhouse R; Bristol Myers Squibb Research and Development, 100 Binney St, Cambridge, MA 02142-1096, USA.
  • Xie C; Bristol Myers Squibb Research and Development, 100 Binney St, Cambridge, MA 02142-1096, USA.
  • Zhao J; Bristol Myers Squibb Research and Development, 100 Binney St, Cambridge, MA 02142-1096, USA.
  • Huang L; Bristol Myers Squibb Research and Development, 100 Binney St, Cambridge, MA 02142-1096, USA.
  • Sheriff S; Bristol Myers Squibb Research and Development, 100 Binney St, Cambridge, MA 02142-1096, USA.
  • Yan C; Bristol Myers Squibb Research and Development, 100 Binney St, Cambridge, MA 02142-1096, USA.
  • Marsilio F; Bristol Myers Squibb Research and Development, 100 Binney St, Cambridge, MA 02142-1096, USA.
  • Everlof G; Bristol Myers Squibb Research and Development, 100 Binney St, Cambridge, MA 02142-1096, USA.
  • Zvyaga T; Bristol Myers Squibb Research and Development, 100 Binney St, Cambridge, MA 02142-1096, USA.
  • Lee F; Bristol Myers Squibb Research and Development, 100 Binney St, Cambridge, MA 02142-1096, USA.
  • Gavai AV; Bristol Myers Squibb Research and Development, 100 Binney St, Cambridge, MA 02142-1096, USA.
  • Degnan AP; Bristol Myers Squibb Research and Development, 100 Binney St, Cambridge, MA 02142-1096, USA.
Bioorg Med Chem Lett ; 51: 128376, 2021 11 01.
Article em En | MEDLINE | ID: mdl-34560263

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carbolinas / Proteínas / Neoplasias de Mama Triplo Negativas / Desenvolvimento de Medicamentos / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Bioorg Med Chem Lett Assunto da revista: BIOQUIMICA / QUIMICA Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carbolinas / Proteínas / Neoplasias de Mama Triplo Negativas / Desenvolvimento de Medicamentos / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Bioorg Med Chem Lett Assunto da revista: BIOQUIMICA / QUIMICA Ano de publicação: 2021 Tipo de documento: Article